Kresten Skak
Publications by Year
Research Areas
Immune Cell Function and Interaction, Nonmelanoma Skin Cancer Studies, Immunotherapy and Immune Responses, Nail Diseases and Treatments, CAR-T cell therapy research
Most-Cited Works
- → An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma(2007)165 cited
- → Interleukin‐21 activates human natural killer cells and modulates their surface receptor expression(2007)155 cited
- → Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial(2009)138 cited
- → IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma(2008)114 cited
- → Interleukin 21: combination strategies for cancer therapy(2008)103 cited
- → Interleukin-21 Signaling: Functions in Cancer and Autoimmunity(2007)90 cited
- → Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression(2003)75 cited
- → Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis(2016)72 cited
- → Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors(2007)70 cited
- → IL‐21: roles in immunopathology and cancer therapy(2009)65 cited